F. Hansmannel, M. C. Clemencet, L. Jossic-corcos, C. Osumi, T. Latruffe et al., Functional characterization of a peroxisome proliferator response-element located in the intron 3 of rat peroxisomal thiolase B gene, Biochemical and Biophysical Research Communications, vol.311, issue.1, pp.149-155, 2003.
DOI : 10.1016/j.bbrc.2003.09.185

T. Helledie, L. Grontved, S. S. Jensen, P. Kiilerich, L. Rietveld et al., The Gene Encoding the Acyl-CoA-binding Protein Is Activated by Peroxisome Proliferator-activated Receptor gamma through an Intronic Response Element Functionally Conserved between Humans and Rodents, Journal of Biological Chemistry, vol.277, issue.30, pp.26821-26830, 2002.
DOI : 10.1074/jbc.M111295200

S. Mandard, F. Zandbergen, N. S. Tan, P. Escher, D. Patsouris et al., The Direct Peroxisome Proliferator-activated Receptor Target Fasting-induced Adipose Factor (FIAF/PGAR/ANGPTL4) Is Present in Blood Plasma as a Truncated Protein That Is Increased by Fenofibrate Treatment, Journal of Biological Chemistry, vol.279, issue.33, pp.34411-34420, 2004.
DOI : 10.1074/jbc.M403058200

L. Napal, P. F. Marrero, and D. Haro, An Intronic Peroxisome Proliferator-activated Receptor-binding sequence Mediates Fatty Acid Induction of the Human Carnitine Palmitoyltransferase 1A, Journal of Molecular Biology, vol.354, issue.4, pp.751-759, 2005.
DOI : 10.1016/j.jmb.2005.09.097

P. Escher, O. Braissant, S. Basu-modak, L. Michalik, W. Wahli et al., Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding, Endocrinology, vol.142, issue.10, pp.4195-4202, 2001.
DOI : 10.1210/endo.142.10.8458

S. Kersten, J. Seydoux, J. M. Peters, F. J. Gonzalez, B. Desvergne et al., Peroxisome proliferator???activated receptor ?? mediates the adaptive response to fasting, Journal of Clinical Investigation, vol.103, issue.11, pp.1489-1498, 1999.
DOI : 10.1172/JCI6223

T. C. Leone, C. J. Weinheimer, and D. P. Kelly, A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalphanull mouse as a model of fatty acid oxidation disorders, Proc. Natl. Acad. Sci. USA 96, pp.7473-7478, 1999.

S. Kersten, S. Mandard, P. Escher, F. J. Gonzalez, S. Tafuri et al., The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism, The FASEB Journal, vol.15, issue.11, 1971.
DOI : 10.1096/fj.01-0147com

S. 10-mandard, M. Muller, and S. Kersten, Peroxisome proliferator-activated receptor a target genes, Cellular and Molecular Life Sciences (CMLS), vol.61, issue.4, pp.393-416, 2004.
DOI : 10.1007/s00018-003-3216-3

D. 11-patsouris, S. Mandard, P. J. Voshol, P. Escher, N. S. Tan et al., PPAR?? governs glycerol metabolism, Journal of Clinical Investigation, vol.114, issue.1, pp.94-103, 2004.
DOI : 10.1172/JCI20468DS1

P. 12-gervois, R. Kleemann, A. Pilon, F. Percevault, W. Koenig et al., Global Suppression of IL-6-induced Acute Phase Response Gene Expression after Chronic in Vivo Treatment with the Peroxisome Proliferator-activated Receptor-?? Activator Fenofibrate, Journal of Biological Chemistry, vol.279, issue.16, pp.16154-16160, 2004.
DOI : 10.1074/jbc.M400346200

T. 13-nakajima, Y. Kamijo, N. Tanaka, E. Sugiyama, E. Tanaka et al., Peroxisome proliferator-activated receptor ? protects against alcohol-induced liver damage, Hepatology, vol.26, issue.4, pp.972-980, 2004.
DOI : 10.1002/hep.20399

A. C. Li, C. J. Binder, A. Gutierrez, K. K. Brown, C. R. Plotkin et al., Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPAR??, ??/??, and ??, Journal of Clinical Investigation, vol.114, issue.11, pp.1564-1576, 2004.
DOI : 10.1172/JCI18730

B. N. Finck, C. Bernal-mizrachi, D. H. Han, T. Coleman, N. Sambandam et al., A potential link between muscle peroxisome proliferator- activated receptor-?? signaling and obesity-related diabetes, Cell Metabolism, vol.1, issue.2, pp.133-144, 2005.
DOI : 10.1016/j.cmet.2005.01.006

B. N. 16-finck, J. J. Lehman, T. C. Leone, M. J. Welch, M. J. Bennett et al., The cardiac phenotype induced by PPAR?? overexpression mimics that caused by diabetes mellitus, Journal of Clinical Investigation, vol.109, issue.1, pp.121-130, 2002.
DOI : 10.1172/JCI0214080

W. Wahli, P. Chambon, and D. Metzger, Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse, 2004.

E. D. Rosen, P. Sarraf, A. E. Troy, G. Bradwin, K. Moore et al., PPAR?? Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro, Molecular Cell, vol.4, issue.4, pp.611-617, 1999.
DOI : 10.1016/S1097-2765(00)80211-7

S. Luquet, J. Lopez-soriano, D. Holst, A. Fredenrich, J. Melki et al., Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability, FASEB J, vol.17, pp.2299-2301, 2003.

T. Tanaka, J. Yamamoto, S. Iwasaki, H. Asaba, H. Hamura et al., Activation of peroxisome proliferator-activated receptor delta induces fatty acid betaoxidation in skeletal muscle and attenuates metabolic syndrome, Proc. Natl. Acad. Sci. USA, pp.15924-15929, 2003.

Y. X. Wang, C. H. Lee, S. Tiep, R. T. Yu, J. Ham et al., Peroxisome-Proliferator-Activated Receptor ?? Activates Fat Metabolism to Prevent Obesity, Cell, vol.113, issue.2, pp.159-170, 2003.
DOI : 10.1016/S0092-8674(03)00269-1

Y. X. Wang, C. L. Zhang, R. T. Yu, H. K. Cho, M. C. Nelson et al., Regulation of Muscle Fiber Type and Running Endurance by PPAR??, PLoS Biology, vol.98, issue.10, p.294, 2004.
DOI : 10.1371/journal.pbio.0020294.sv002

T. E. Akiyama, G. Lambert, C. J. Nicol, K. Matsusue, J. M. Peters et al., Peroxisome Proliferator-activated Receptor ??/?? Regulates Very Low Density Lipoprotein Production and Catabolism in Mice on a Western Diet, Journal of Biological Chemistry, vol.279, issue.20, pp.20874-20881, 2004.
DOI : 10.1074/jbc.M312802200

P. N. Di, N. S. Tan, L. Michalik, W. Wahli, and B. Desvergne, Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway, Mol. Cell, vol.10, pp.721-733, 2002.

R. A. Gupta, D. Wang, S. Katkuri, H. Wang, S. K. Dey et al., Activation of nuclear hormone receptor peroxisome proliferator???activated receptor-?? accelerates intestinal adenoma growth, Nature Medicine, vol.10, issue.3, pp.245-247, 2004.
DOI : 10.1038/nm993

K. 26-nadra, S. I. Anghel, E. Joye, N. S. Tan, S. Basu-modak et al., Differentiation of Trophoblast Giant Cells and Their Metabolic Functions Are Dependent on Peroxisome Proliferator-Activated Receptor ??/??, Molecular and Cellular Biology, vol.26, issue.8, pp.3266-3281, 2006.
DOI : 10.1128/MCB.26.8.3266-3281.2006

J. Rieusset, J. Seydoux, S. I. Anghel, P. Escher, L. Michalik et al., Altered Growth in Male Peroxisome Proliferator-Activated Receptor ?? (PPAR??) Heterozygous Mice: Involvement of PPAR?? in a Negative Feedback Regulation of Growth Hormone Action, Molecular Endocrinology, vol.18, issue.10, pp.2363-2377, 2004.
DOI : 10.1210/me.2003-0325

G. P. Hayhurst, Y. H. Lee, G. Lambert, J. M. Ward, and F. J. Gonzalez, Hepatocyte Nuclear Factor 4?? (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis, Molecular and Cellular Biology, vol.21, issue.4, pp.1393-1403, 2001.
DOI : 10.1128/MCB.21.4.1393-1403.2001

F. 29-kuipers, M. C. Jong, Y. Lin, M. Eck, R. Havinga et al., Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes., Journal of Clinical Investigation, vol.100, issue.11, pp.2915-2922, 1997.
DOI : 10.1172/JCI119841

M. C. 30-sugden, K. Bulmer, G. F. Gibbons, B. L. Knight, and M. J. Holness, Peroxisome-proliferator-activated receptor-?? (PPAR??) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin, Biochemical Journal, vol.364, issue.2, pp.361-368, 2002.
DOI : 10.1042/bj20011699

J. Xu, G. Xiao, C. Trujillo, V. Chang, L. Blanco et al., Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) Influences Substrate Utilization for Hepatic Glucose Production, Journal of Biological Chemistry, vol.277, issue.52, pp.50237-50244, 2002.
DOI : 10.1074/jbc.M201208200

R. H. Bandsma, T. H. Van-dijk, A. At, T. Kok, D. J. Reijngoud et al., Hepatic de Novo Synthesis of Glucose 6-Phosphate Is Not Affected in Peroxisome Proliferator-activated Receptor ??-Deficient Mice but Is Preferentially Directed toward Hepatic Glycogen Stores after a Short Term Fast, Journal of Biological Chemistry, vol.279, issue.10, pp.8930-8937, 2004.
DOI : 10.1074/jbc.M310067200

M. Podvinec, M. R. Kaufmann, C. Handschin, and U. A. Meyer, Approach for Prediction of Nuclear Receptor Response Elements, Molecular Endocrinology, vol.16, issue.6, pp.1269-1279, 2002.
DOI : 10.1210/mend.16.6.0851

A. 34-sandelin and W. W. Wasserman, Prediction of Nuclear Hormone Receptor Response Elements, Molecular Endocrinology, vol.19, issue.3, pp.595-606, 2005.
DOI : 10.1210/me.2004-0101

F. 35-parviz, C. Matullo, W. D. Garrison, L. Savatski, J. W. Adamson et al., Hepatocyte nuclear factor 4?? controls the development of a hepatic epithelium and liver morphogenesis, Nature Genetics, vol.34, issue.3, pp.292-296, 2003.
DOI : 10.1038/ng1175

D. T. Odom, N. Zizlsperger, D. B. Gordon, G. W. Bell, N. J. Rinaldi et al., Control of Pancreas and Liver Gene Expression by HNF Transcription Factors, Science, vol.303, issue.5662, pp.1378-1381, 2004.
DOI : 10.1126/science.1089769

N. S. 37-tan, L. Michalik, N. Noy, R. Yasmin, C. Pacot et al., Critical roles of PPARbeta /delta in keratinocyte response to inflammation, Genes & Development, vol.15, issue.24, pp.3263-3277, 2001.
DOI : 10.1101/gad.207501

L. Cheng, G. Ding, Q. Qin, Y. Huang, W. Lewis et al., Cardiomyocyte-restricted peroxisome proliferator-activated receptor-?? deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy, Nature Medicine, vol.285, issue.11, pp.1245-1250, 2004.
DOI : 10.1016/0006-2952(78)90042-4

U. Dressel, T. L. Allen, J. B. Pippal, P. R. Rohde, P. Lau et al., The Peroxisome Proliferator-Activated Receptor ??/?? Agonist, GW501516, Regulates the Expression of Genes Involved in Lipid Catabolism and Energy Uncoupling in Skeletal Muscle Cells, Molecular Endocrinology, vol.17, issue.12, pp.2477-2493, 2003.
DOI : 10.1210/me.2003-0151

S. 40-terada, S. Wicke, J. O. Holloszy, and D. H. Han, PPAR?? activator GW-501516 has no acute effect on glucose transport in skeletal muscle, AJP: Endocrinology and Metabolism, vol.290, issue.4, pp.607-611, 2006.
DOI : 10.1152/ajpendo.00430.2005

D. Antwi, J. H. Youn, N. S. Shargill, D. D. Lesikar, and H. R. Kaslow, Regulation of glycogen synthase in muscle and adipose tissue during fasting and refeeding, Am. J. Physiol, vol.254, pp.720-725, 1988.

H. P. Guan, Y. Li, M. V. Jensen, C. B. Newgard, C. M. Steppan et al., A futile metabolic cycle activated in adipocytes by antidiabetic agents, Nature Medicine, vol.50, issue.10, pp.1122-1128, 2002.
DOI : 10.1038/nm0202-179

K. Matsusue, J. M. Peters, and F. J. Gonzalez, PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation, FASEB J, vol.18, pp.1477-1479, 2004.

M. Orho, N. U. Bosshard, N. R. Buist, R. Gitzelmann, A. Aynsley-green et al., Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0., Journal of Clinical Investigation, vol.102, issue.3, pp.507-515, 1998.
DOI : 10.1172/JCI2890

D. A. 45-weinstein, C. E. Correia, A. C. Saunders, and J. I. Wolfsdorf, Hepatic glycogen synthase deficiency: An infrequently recognized cause of ketotic hypoglycemia, Molecular Genetics and Metabolism, vol.87, issue.4, pp.284-288, 2006.
DOI : 10.1016/j.ymgme.2005.10.006